The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID.
Saved in:
| Title: | The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID. |
|---|---|
| Authors: | Helmueller S; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Song X; Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA., Kim DH; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, USA.; Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, IL, USA., Lee YJ; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. |
| Source: | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2025 Dec; Vol. 42 (1), pp. 2544017. Date of Electronic Publication: 2025 Aug 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8508395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5157 (Electronic) Linking ISSN: 02656736 NLM ISO Abbreviation: Int J Hyperthermia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
